Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: J Appl Biobehav Res. 2013 Mar 8;18(1):37–57. doi: 10.1111/jabr.12003

Table 2.

Psychosocial and immunological outcome variables at baseline (T1) and post-intervention (T2).

CBSM CONTROL
MEAN SD MEAN SD
Outcome Variables
BDI-Total T1: 8.98(10.08)
T2: 6.91(10.07)
T1: 10(9.61)
T2: 10.38(2.26)
BDI-Cognitive Affective T1: 5.86(7.43)
T2: 6.91(10.07)
T1: 7.68(7.88)
T2: 10.38(2.26)
BDI-Somatic T1: 3.04(3.34)
T2: 2.31(3.08)
T1: 2.32(2.19)
T2: 3.43(3.01)
CD4 cells/mm3 T1: 422.21(266.17)
T2: 442.61(306.33)
T1: 462.56(327.46)
T2: 386.50(249.80)
NK cells/mm3 T1: 97.71(60.26)
T2: 88.33(54.28)
T1: 102.32(126.55)
T2: 62.11(41.44)
Viral Load copies/mm3 T1: 29, 513.48 (117,239.784)
T2: 12,462.90 (28,331.98)
T1: 21, 358.16 (37,221.72)
T2: 16,911.06 (24,196.618)

SD= Standard Deviation